Thursday, July 15, 2010

Glaxo agrees to pay $460 million to settle Avandia lawsuits

Just as an FDA panel was meeting to determine whether to recommend to withdraw Avandia from the market, Bloomberg News, Pharmalot and AboutLawsuits are reporting that GlaxoSmithKline has agreed to pay $460 million to settle Avandia lawsuits filed by about 10,000 more people. The settlement would resolve the majority of the outstanding Avandia lawsuits that have been filed against GlaxoSmithKline alleging that they failed to warn about the increased risk of heart attacks and other potentially life-threatening heart problems with Avandia.

No comments: